Advertisement
Australia markets open in 1 hour 56 minutes
  • ALL ORDS

    8,058.60
    +59.40 (+0.74%)
     
  • AUD/USD

    0.6660
    +0.0029 (+0.44%)
     
  • ASX 200

    7,788.30
    +60.70 (+0.79%)
     
  • OIL

    78.55
    +0.83 (+1.07%)
     
  • GOLD

    2,352.50
    +18.00 (+0.77%)
     
  • Bitcoin AUD

    104,530.92
    +1,599.11 (+1.55%)
     
  • CMC Crypto 200

    1,497.18
    +12.98 (+0.87%)
     

Akebia Awaits FDA Word On Second Crack At Vadadustat

Akebia Awaits FDA Word On Second Crack At Vadadustat

The FDA, which turned away Akebia's initial application last March 2022, has a target action of Wednesday on the company's resubmission, which included safety data from tens of thousands of patients in Japan, where vadadustat was approved in mid-2020. Akebia has said it is prepping for a U.S. commercial launch of vadadustat in the second half if it gets an FDA green light.